KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pfizer (PFE) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $0.62.

  • Pfizer's EPS (Weighted Average and Diluted) fell 2151.9% to $0.62 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.44, marking a year-over-year increase of 22105.26%. This contributed to the annual value of $0.0 for FY2024, which is 9947.84% down from last year.
  • Pfizer's EPS (Weighted Average and Diluted) amounted to $0.62 in Q3 2025, which was down 2151.9% from $0.51 recorded in Q2 2025.
  • Pfizer's EPS (Weighted Average and Diluted)'s 5-year high stood at $1.73 during Q3 2022, with a 5-year trough of -$0.59 in Q4 2023.
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was $0.54 (2024), whereas its average is $0.53.
  • Per our database at Business Quant, Pfizer's EPS (Weighted Average and Diluted) tumbled by 12781.46% in 2023 and then skyrocketed by 31488500.0% in 2024.
  • Over the past 5 years, Pfizer's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.0 in 2021, then skyrocketed by 66598.08% to $1.51 in 2022, then crashed by 139.07% to -$0.59 in 2023, then surged by 233.9% to $0.79 in 2024, then fell by 21.52% to $0.62 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $0.62 for Q3 2025, versus $0.51 for Q2 2025 and $0.52 for Q1 2025.